Charles River Laboratories Intl

Alfred Osborne
January 13, 2018

The company had revenue of $464.23 million during the quarter, compared to analyst estimates of $458.93 million. For the next year, analysts forecast that the company will post sales of $1.99 billion per share, with estimates ranging from $1.97 billion to $2.00 billion. In the last quarter, insiders have bought 10,500 shares of company stock worth $2,885 and have sold 1,064,673 shares worth $2,876,056. About 181,715 shares traded. Charles River Laboratories International, Inc. (NYSE:CRL) has risen 7.06% since January 12, 2017 and is uptrending. It has underperformed by 9.64% the S&P500. Gsa Capital Llp reported 110,388 shares. The medical research company reported $1.30 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $1.22 by $0.08. Praesidium Investment Management Company Llc who had been investing in Quanex Building Products Cor for a number of months, seems to be bullish on the $789.08 million market cap company. The stock increased 3.26% or $0.75 during the last trading session, reaching $23.78. About 610,439 shares traded or 62.48% up from the average. Iconix Brand Group, Inc. Gentex Corporation (NASDAQ:GNTX) has risen 19.63% since January 10, 2017 and is uptrending. It has underperformed by 25.78% the S&P500. Six investment analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the stock. Therefore 40% are positive. Charles River Laboratories had 39 analyst reports since August 3, 2015 according to SRatingsIntel. Barclays Capital upgraded the stock to "Equal Weight" rating in Wednesday, November 30 report. The stock of Iconix Brand Group, Inc. As per Wednesday, April 27, the company rating was maintained by CLSA. As per Monday, July 10, the company rating was maintained by KeyBanc Capital Markets. Nomura downgraded the shares of ICON in report on Friday, August 7 to " rating. The rating was downgraded by Brean Capital to "Hold" on Friday, November 6.

Investors sentiment decreased to 0.92 in 2017 Q3. Its up 0.09, from 1.37 in 2017Q2. It worsened, as 8 investors sold RLGT shares while 29 reduced holdings. 8 funds opened positions while 30 raised stakes. (NASDAQ:ICON) for 51,420 shares.

Bandera Partners Llc holds 19.59% of its portfolio in Tandy Leather Factory, Inc. for 2.86 million shares. Bluecrest Management Limited has invested 0.01% in Iconix Brand Group, Inc. Praesidium Investment Management Company Llc bought 26,928 shares as the company's stock rose 2.34% with the market. State Of New Jersey Common Pension Fund D stated it has 35,000 shares or 0.02% of all its holdings. 596,829 were reported by Prudential Financial. Ajo LP invested 0.01% in Radiant Logistics, Inc. Accern also gave headlines about the medical research company an impact score of 47.9103665648042 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the immediate future. (NYSE:CRL). Bluemountain Capital Mngmt Ltd Liability Corp holds 0.03% or 12,863 shares. 505,207 were reported by Geode Cap Mngmt. Wesbanco Bancshares holds 0.05% or 8,344 shares. Jefferies maintained Charles River Laboratories International, Inc. Inc (NYSE:CRL) Director Robert J. Bertolini sold 3,609 shares of the business's stock in a transaction dated Tuesday, January 2nd.

Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery and development services worldwide. (NYSE:CRL) shares. 4,000 Charles River Laboratories International, Inc. Barbo William D sold $399,632 worth of stock.

Rugby Australia announces equal pay deal for men's & women's sevens sides
In another boost, men's and women's sevens players' base pay has been raised to equal their XV-a-side colleagues. Western Australia will continue to play in the National Rugby Championship for the length of the agreement.

LPL Financial (NASDAQ:LPLA) Upgraded at Morgan Stanley
Great West Life Assurance Communication Can invested in 0% or 4,287 shares. 54,100 were accumulated by Fuller & Thaler Asset Mgmt. State of Wisconsin Investment Board increased its position in shares of LPL Financial by 2.9% during the second quarter.

Alabama freshman WR Devonta Smith seals national title with game-winning catch
Palet noted that Hurt, an excellent rusher, had guided the Tide to a 25-2 record while directing the offense to 61 touchdowns. In two quarters against the Bulldogs, he threw for 166 yards and three touchdowns while gaining 27 yards on the ground.

Healthinvest Partners Ab, which manages about $85.64 million US Long portfolio, upped its stake in Mckesson Corp (NYSE:MCK) by 5,500 shares to 68,600 shares, valued at $10.54M in 2017Q3, according to the filing.

First Analysis also issued estimates for Charles River Laboratories Intl.'s Q2 2018 earnings at $1.43 EPS, Q3 2018 earnings at $1.38 EPS and FY2018 earnings at $5.50 EPS. Its up 0.09, from 1.37 in 2017Q2. (NYSE:CRL). Columbus Circle Investors has 22,390 shares for 0.04% of their portfolio. 55 funds opened positions while 106 raised stakes. Inc has a fifty-two week low of $77.61 and a fifty-two week high of $119.05. (NYSE:CRL). Quantitative Investment Mgmt Ltd Liability Corporation stated it has 65,900 shares. Rhumbline Advisers reported 104,812 shares stake. (NYSE:CRL) or 14,015 shares. Morgan Stanley reported 899,582 shares. Moreover, Advantus Cap Management has 0.02% invested in Charles River Laboratories International, Inc. Hutchin Hill Cap Limited Partnership reported 0.03% stake. (NYSE:CRL). 15,156 were accumulated by Jefferies Gp Limited Co. Da Davidson And has invested 0.01% in Gentex Corporation (NASDAQ:GNTX). (NYSE:CRL) for 98,584 shares. First Quadrant LP Ca accumulated 6,010 shares. Oakbrook Invs Limited Co, a Illinois-based fund reported 4,517 shares.

Among 33 analysts covering Teva Pharma (NYSE:TEVA), 9 have Buy rating, 7 Sell and 17 Hold. Charles River Laboratories Intl.'s revenue was up 9.0% compared to the same quarter a year ago. Jefferies maintained Charles River Laboratories International, Inc. (NYSE:CRL) on Friday, January 8 with "Buy" rating. (NYSE:CRL) on Tuesday, September 6 to "Sell" rating. As per Monday, November 13, the company rating was maintained by Robert W. Baird. The firm has "Neutral" rating given on Tuesday, June 21 by Credit Suisse. The stock of Charles River Laboratories International, Inc. (NYSE:CRL) on Thursday, November 16 with "Buy" rating. 24,759 Charles River Laboratories International, Inc. The rating was maintained by William Blair with "Outperform" on Friday, August 28. Wells Fargo upgraded Charles River Laboratories International, Inc. (NYSE:CRL) on Monday, October 12 to "Market Perform" rating. 24,759 Charles River Laboratories International, Inc. They expect $1.26 EPS, up 4.13% or $0.05 from last year's $1.21 per share. CRL's profit will be $59.67M for 21.05 P/E if the $1.26 EPS becomes a reality. Virginia Retirement Systems ET AL acquired a new stake in Charles River Laboratories International during the third quarter valued at approximately $383,000.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Other reports by

Discuss This Article